298 related articles for article (PubMed ID: 9931149)
1. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M
Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149
[TBL] [Abstract][Full Text] [Related]
2. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF
J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309
[TBL] [Abstract][Full Text] [Related]
3. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.
Georgescu A; Pluteanu F; Flonta ML; Badila E; Dorobantu M; Popov D
Eur J Pharmacol; 2005 Jan; 508(1-3):159-66. PubMed ID: 15680267
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta.
Tran Quang T; Rozec B; Audigane L; Gauthier C
Br J Pharmacol; 2009 Feb; 156(4):601-8. PubMed ID: 19210511
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
Feng MG; Prieto MC; Navar LG
Am J Physiol Renal Physiol; 2012 Sep; 303(5):F775-82. PubMed ID: 22674024
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
Toblli JE; Cao G; Casas G; Mazza ON
Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol: endothelium-mediated vasodilating effect.
Ritter JM
J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
[TBL] [Abstract][Full Text] [Related]
8. Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries.
Wang Y; Zhang M; Liu Y; Li J; Song E; Niu L; Cheng N
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):332-8. PubMed ID: 19903983
[TBL] [Abstract][Full Text] [Related]
9. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
Greven J; Gabriëls G
Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
[TBL] [Abstract][Full Text] [Related]
10. Effect of celiprolol therapy on arterial dilatation in experimental hypertension.
Tolvanen JP; Wu X; Kähönen M; Sallinen K; Mäkynen H; Pekki A; Pörsti I
Br J Pharmacol; 1996 Nov; 119(6):1137-44. PubMed ID: 8937716
[TBL] [Abstract][Full Text] [Related]
11. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
12. Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats.
Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Shirataki H; Matsuoka H
J Hypertens; 2001 Apr; 19(4):795-801. PubMed ID: 11330883
[TBL] [Abstract][Full Text] [Related]
13. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
14. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol.
Parenti A; Filippi S; Amerini S; Granger HJ; Fazzini A; Ledda F
J Pharmacol Exp Ther; 2000 Feb; 292(2):698-703. PubMed ID: 10640308
[TBL] [Abstract][Full Text] [Related]
15. Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.
Rozec B; Quang TT; Noireaud J; Gauthier C
Br J Pharmacol; 2006 Apr; 147(7):699-706. PubMed ID: 16474420
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol: a selective beta(1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms.
Ignarro LJ; Byrns RE; Trinh K; Sisodia M; Buga GM
Nitric Oxide; 2002 Sep; 7(2):75-82. PubMed ID: 12223176
[TBL] [Abstract][Full Text] [Related]
17. Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance.
Noda K; Oka M; Ma FH; Kitazawa S; Ukai Y; Toda N
Eur J Pharmacol; 2001 Mar; 415(2-3):209-16. PubMed ID: 11275001
[TBL] [Abstract][Full Text] [Related]
18. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
19. Effects of nebivolol on human platelet aggregation.
Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]